definiens: shall mean ( a ) [ * * * ] ; and ( b ) [ * * * ] both ( a ) and ( b ) in unmodified form and in the stat us of development as of the earlier of the MedImmun e FSAs Effective Dates ( April 24, 2014 ) . For the sake of clarity, the term as used in this Agreement does expressl y not comprise ( i ) any contributions ( either material or immaterial ) of either MedImmune or [COMPANY] to t he performance of the Preceding Service Agreements for the development of the Developed Pro cess and/or the Developed Strain, including Product, genetic material or information coding for Product, the Downstream Process and/or [COMPANY] Background IP ; or ( ii ) any combinations of such con tributions of either MedImmune or [COMPANY] with ( a ) and/or ( b ) - the term as used in this Agreement is strictly limite d to ( a ) and ( b ) as such